56. Behcet disease Clinical trials / Disease details


Clinical trials : 76 Drugs : 110 - (DrugBank : 32) / Drug target genes : 36 - Drug target pathways : 116

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04218565
(ClinicalTrials.gov)
February 15, 20208/12/2019Golimumab for the Treatment of Refractory Behcet's UveitisEfficacy and Safety of Golimumab in the Treatment of Refractory Uveitis in Patients With Behcet's DiseaseBehcet Syndrome;UveitisBiological: Golimumab (GOL)Wenjie ZhengNULLRecruiting18 Years65 YearsAll9Phase 2China